National Science Foundation

Investor type Entrepreneurship Program


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 2537
Average round size
The average size of a deal this fund participated in
Portfolio companies 1880
Rounds per year 35.24
Lead investments 117
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 63
Key employees 9
Stages of investment

Areas of investment

  • Health Care
  • Biotechnology
  • Software
  • Manufacturing
  • Medical

National Science Foundation is the famous VC, which was founded in 1950. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the Alexandria.

The top activity for fund was in 2019. Comparing to the other companies, this National Science Foundation performs on 24 percentage points less the average number of lead investments. The typical startup value when the investment from National Science Foundation is 1-5 millions dollars. The usual things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in 7-12 investment rounds annually. The higher amount of exits for fund were in 2013. The real fund results show that this VC is 23 percentage points more often commits exit comparing to other companies.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight Symantec, Affectiva, Agrivida. Among the most successful fund investment fields, there are Software, Universities. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the National Science Foundation, startups are often financed by MassChallenge, US Department of Energy, Massachusetts Technology Collaborative. The meaningful sponsors for the fund in investment in the same round are National Institutes of Health, US Department of Energy, U.S. Environmental Protection Agency. In the next rounds fund is usually obtained by US Department of Energy, Techstars, Menlo Ventures.

The overall number of key employees were 9.

Read more

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Iaso Therapeutics

Health Care
$978K14 Mar 2022 East Lansing, Michigan, United States

Strados Labs

Artificial Intelligence
Health Care
Medical Device
$990K10 Mar 2022 Philadelphia, Pennsylvania, United States

Lura Health

Health Care
Medical Device
$1M28 Feb 2022 Cambridge, Massachusetts, United States


Health Care
Medical Device
$975K22 Feb 2022 Zionsville, Indiana, United States

Strange Development

Industrial Design
Mechanical Engineering
$1M02 Dec 2021 Detroit, Michigan, United States

Anello Photonics

30 Nov 2021 Santa Clara, California, United States


3D Printing
3D Technology
$256K11 Nov 2021 New York, New York, United States

TruSpin Nanomaterial Innovation, Inc.

Advanced Materials
Energy Storage
$256K10 Nov 2021 Birmingham, Alabama, United States

Aspero Medical

Clinical Trials
Health Care
Medical Device
$1M09 Nov 2021 Boulder, Colorado, United States
Florica Therapeutics, Inc. Awarded Competitive Grant from the National Science Foundation to Study Brain-Immune Axis in COVID-19

– Florica Therapeutics has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $255,678 to work on the Hypothalamus Stem Cell Exosomes for Treatment of COVID-19 project.
– The hypothalamus is crucial to secretion of cortisol and other immune-modulators that dampen the immune response following immune activation.
– Florica Therapeutics is a labor of love dedicated to my mother Florica Ichim.
– When I was 10 years old, my mother was diagnosed with leukemia. I promised her that she would not fight alone, I dedicated my life to extending the lives of others through biomedical research.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent National Science Foundation?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: